The Medicines for Human Use (Administration and Sale or Supply) (Miscellaneous Amendments) Order 2006 © Crown Copyright 2006 Statutory Instruments printed from this website are printed under the superintendence and authority of the Controller of HMSO being the Queen's Printer of Acts of Parliament. The legislation contained on this web site is subject to Crown Copyright protection. It may be reproduced free of charge provided that it is reproduced accurately and that the source and copyright status of the material is made evident to users. It should be noted that the right to reproduce the text of Statutory Instruments does not extend to the Queen's Printer imprints which should be removed from any copies of the Statutory Instrument which are issued or made available to the public. This includes reproduction of the Statutory Instrument on the Internet and on intranet sites. The Royal Arms may be reproduced only where they are an integral part of the original document. The text of this Internet version of the Statutory Instrument which is published by the Queen's Printer of Acts of Parliament has been prepared to reflect the text as it was Made. A print version is also available and is published by The Stationery Office Limited as the The Medicines for Human Use (Administration and Sale or Supply) (Miscellaneous Amendments) Order 2006, ISBN 0110752090. The print version may be purchased by clicking here. Braille copies of this Statutory Instrument can also be purchased at the same price as the print edition by contacting TSO Customer Services on 0870 600 5522 or e-mail: customer.services@tso.co.uk. Further information about the publication of legislation on this website can be found by referring to the Frequently Asked Questions. To ensure fast access over slow connections, large documents have been segmented into "chunks". Where you see a "continue" button at the bottom of the page of text, this indicates that there is another chunk of text available.
The Secretary of State and the Department of Health, Social Services and Public Safety, acting jointly, make the following Order in the exercise of powers conferred upon them by sections 57(1) and (2), 58(4) and (5) and 129(4) of the Medicines Act 1968[1], or, in the case of the Department, the powers conferred by those provisions and now vested in it[2]. In accordance with section 129(6) of that Act, they have consulted such organisations as appear to them to be representative of interests likely to be substantially affected by this Order. In accordance with sections 58(6) and 129(7) of that Act, they have consulted and taken into account the advice of the Commission on Human Medicines[3]. Citation, commencement and interpretation 1. —(1) This Order may be cited as the Medicines for Human Use (Administration and Sale or Supply) (Miscellaneous Amendments) Order 2006 and shall come into force on 17th November 2006. (2) In this Order—
Amendment of article 1 of the POM Order
(d) for the definition of "operator", substitute the following definition—
(b) for the purposes of article 7B, has the same meaning as in the Ionising Radiation (Medical Exposure) Regulations 2000;"; and
(e) after the definition of "prolonged release", insert the following definition—
Insertion of article 7B of the POM Order
7B. —(1) The restriction imposed by section 58(2)(b) (restriction on administration) shall not apply to—
(b) any other prescription only medicine if it is being administered in connection with a medical exposure,
where the conditions specified in paragraph (2) are satisfied.
(b) that medical exposure has been authorised by an IRME practitioner or, where it is not practicable for an IRME practitioner to authorise the exposure, by an operator acting in accordance with written guidelines issued by an IRME practitioner; (c) the IRME practitioner is the holder of a certificate granted pursuant to the Medicines (Administration of Radioactive Substances) Regulations 1978[7]; (d) the radioactive medicinal product or other prescription only medicine is not a controlled drug; and (e) in the case of a prescription only medicine which is not a radioactive medicinal product, it is specified in the protocols referred to in sub-paragraph (a)."
Amendment of Schedule 5 to the POM Order
(ii) in sub-paragraph (d), for "in weight." substitute "in weight; and", and (iii) at the end, add—
(f) Erythromycin; (g) Flucoxacillin; (h) Tioconazole 28% ; and (i) Silver Sulfadiazine."
(3) In Part II (exemptions from the restriction on supply), after paragraph 7 insert—
Amendment of Schedule 1 to the Pharmacy and General Sale Order
(ii) for paragraph 1A substitute the following paragraph—
(bb) after "acid" insert "1.0 per cent Terbinafine", and
(ii) in paragraph 1A(a)—
(bb) after "1 per cent by weight in weight;" insert—
(vi) Erythromycin; (vii) Flucoxacillin; (viii) Tioconazole 28% ; and (ix) Silver Sulfadiazine;".
(3) In Part II, after paragraph 14 insert—
(This note is not part of the Order) This Order makes further amendments to certain Orders relating to the administration and sale or supply of medicines. Articles 2 to 4 amend the Prescription Only Medicines (Human Use) Order 1997 ("the POM Order") which specifies the description and classes of medicines ("prescription only medicines") which may be sold or supplied only in accordance with the prescription of an "appropriate practitioner" and may be administered only by or in accordance with the directions of such a practitioner. Article 2 amends article 1 of the POM Order and article 3 inserts a new article 7B in order to create an exemption from the requirement that a prescription only medicine may only be administered by an appropriate practitioner or a person acting in accordance with his directions. In particular article 3 makes provision for persons who are operators under the Ionising Radiation (Medical Exposure) Regulations 2000 ("the IRME Regulations") to administer radioactive medicinal products or other prescription only medicines administered in connection with medical exposures under those Regulations. The operator must be acting in accordance with the relevant procedures and protocols under the IRME Regulations. In addition, the operator must be acting under the authorisation of, or in accordance with the written guidelines of, a person who is a practitioner under the IRME Regulations and the holder of a certificate under the Medicines (Administration of Radioactive Substances) Regulations 1978. Article 2(c) makes an amendment to the definition of "medicinal product" consequential on the amendments made to the Medicines Act 1968 by Schedule 8 to the Veterinary Medicines Regulations 2006[8]. Those Regulations amend the Act so that it no longer applies to veterinary medicinal products. Article 4(2) and (4) amends Parts I and III of Schedule 5 to the POM Order (exemption for certain persons from section 58(2) of the Act) to extend the list of prescription only medicines which may be sold or supplied or administered by chiropodists and podiatrists in the course of their professional practice. Articles 4(3) and 5(3) amend Part II of Schedule 5 to the POM Order and Part II of Schedule 1 to the Medicines (Pharmacy and General Sale—Exemption) Order 1980 ("the Pharmacy and General Sale Order"), respectively. These articles create exemptions for persons holding a certificate in first aid from the Mountain Rescue Council of England and Wales or the Northern Ireland Rescue Co-ordinating Committee, to enable them to supply pharmacy and general sale list medicines or prescription only medicines for the treatment of sick or injured persons. Article 5(2) amends Part I of Schedule 1 to the Pharmacy and General Sale Order which provides exemptions from sections 52 and 53 of the Medicines Act 1968 (restrictions on sale or supply of medicinal products). Article 5(2) extends the list of medicines which may be sold or supplied by chiropodists and podiatrists in the course of their professional practice. Articles 4(2)(a) and (4)(a) and 5(2) also make amendments consequential on earlier amending Orders. A full regulatory impact assessment of the effect that this instrument will have on the costs of business is available from the Medicines and Healthcare products Regulatory Agency, Market Towers, 1 Nine Elms Lane, London SW8 5NQ. Copies of the assessment have been placed in the libraries of both Houses of Parliament. Notes: [1] 1968 c.67. The expression "the Ministers", which is relevant to the powers being exercised in the making of this Order, is defined in section 1 of the Act as amended by Schedule 1 to S.I. 1969/388, paragraph 1(1) of the Schedule to S.I. 1999/3142 and paragraph 2 of Part 1 of Schedule 8 to S.I. 2006/2407; section 57(1) of that Act was amended by paragraph 28(1) of Schedule 8 to S.I. 2006/2407; section 58 of that Act was amended by section 1 of the Prescription by Nurses etc. Act 1992 (c. 28), by section 63 of the Health and Social Care Act 2001 (c.15), by paragraph 2 of Schedule 5 to S.I. 2002/253, by paragraph 10 of Schedule 1 to S.I. 2005/1094 and by paragraph 29 of Part 1 of Schedule 8 to S.I. 2006/2407.back [2] By virtue of the powers vested in the Ministers in charge of that Department by virtue of section 95(5) of, and paragraph 10 of Schedule 12 to, the Northern Ireland Act 1998 (c.47), which may now be exercised by the Department by virtue of section 1(8) of, and paragraph 4(1)(b) of the Schedule to, the Northern Ireland Act 2000 (c.1); the Department was renamed by virtue of Article 3(6) of S.I. 1999/283 (N.I.1.).back [3] The expression "the appropriate committee", referred to in section 58(6) of the Act, is defined in section 4(6) of the Act, as amended by S.I. 2005/1094.back [4] S.I. 1997/1830; relevant amending instruments are S.I. 1998/108 and 2081, 2003/1590 and 2004/2693.back [5] S.I. 1980/1924; relevant amending instruments are S.I. 1982/27, 1998/107 and 2005/766.back [6] S.I. 2000/1059, amended by S.I. 2004/1031 and 2006/2523.back [7] S.I. 1978/1006, amended by S.I. 1995/2147 and 2005/2754.back
ISBN 0 11 075209 0
|
|
| ||
| We welcome your comments on this site | © Crown copyright 2006 | Prepared 26 October 2006 |